Sodium–glucose cotransporter 2 inhibitors improved time‐in‐range without increasing hypoglycemia in Japanese patients with type 1 diabetes: A retrospective, single‐center, pilot study

AIMS/INTRODUCTION: Studies have shown that sodium–glucose cotransporter 2 (SGLT2) inhibitors increased time‐in‐range (TIR; percentage of time glucose level remains between 3.9 and 10.0 mmol/L [70–180 mg/dL]) and decreased glycemic variability in patients with type 1 diabetes. The aim of this study w...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Daisuke, Yamada, Hodaka, Yoshida, Masashi, Funazaki, Shunsuke, Amamoto, Misato, Morimoto, Jun, Hara, Kazuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477508/
https://www.ncbi.nlm.nih.gov/pubmed/32100964
http://dx.doi.org/10.1111/jdi.13240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7477508/
https://www.ncbi.nlm.nih.gov/pubmed/32100964
http://dx.doi.org/10.1111/jdi.13240

Ejemplares similares